My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy.

    Mira JP, Max A, Burgel PR.

    Crit Care. 2008;12 Suppl 6:S5. Epub 2008 Nov 26. Review.PMID: 19105798 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition.

    Laterre PF.

    Crit Care. 2008;12 Suppl 6:S4. Epub 2008 Nov 26. Review.PMID: 19105797 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.

    Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, Bates B, Yan SC, Dhainaut JF; PROWESS Clinical Evaluation Committee.

    Crit Care Med. 2005 May;33(5):952-61.PMID: 15891319 [PubMed - indexed for MEDLINE]Related articles

    4.

    A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia.

    Laterre PF, Opal SM, Abraham E, LaRosa SP, Creasey AA, Xie F, Poole L, Wunderink RG.

    Crit Care. 2009;13(2):R36. Epub 2009 Mar 15.PMID: 19284881 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae.

    Vail GM, Xie YJ, Haney DJ, Barnes CJ.

    Infection. 2009 Aug;37(4):358-64. Epub 2009 Jan 23.PMID: 19169631 [PubMed - indexed for MEDLINE]Related articles

    6.

    Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

    Chalmers JD, Singanayagam A, Scally C, Hill AT.

    Ann Emerg Med. 2009 May;53(5):633-8. Epub 2009 Feb 7.PMID: 19201061 [PubMed - indexed for MEDLINE]Related articles

    7.

    Improving outcomes of elderly patients with community-acquired pneumonia.

    Gutiérrez F, Masiá M.

    Drugs Aging. 2008;25(7):585-610. Review.PMID: 18582147 [PubMed - indexed for MEDLINE]Related articles

    8.

    Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?

    Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC.

    Chest. 2006 Apr;129(4):968-78.PMID: 16608946 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

    Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM.

    Chest. 2009 Sep;136(3):823-31. Epub 2009 Apr 10.PMID: 19363212 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of systemic steroids in patients with severe community-acquired pneumonia.

    Garcia-Vidal C, Calbo E, Pascual V, Ferrer C, Quintana S, Garau J.

    Eur Respir J. 2007 Nov;30(5):951-6. Epub 2007 Aug 9.PMID: 17690125 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.

    Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I.

    Chest. 2005 Oct;128(4):2223-9.PMID: 16236878 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.

    Yandiola PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A.

    Chest. 2009 Jun;135(6):1572-9. Epub 2009 Jan 13.PMID: 19141524 [PubMed - indexed for MEDLINE]Related articles

    13.

    Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.

    Schuetz P, Stolz D, Mueller B, Morgenthaler NG, Struck J, Mueller C, Bingisser R, Tamm M, Christ-Crain M.

    BMC Infect Dis. 2008 Feb 28;8:22.PMID: 18304365 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Corticosteroid treatment of severe community-acquired pneumonia.

    Gorman SK, Slavik RS, Marin J.

    Ann Pharmacother. 2007 Jul;41(7):1233-7. Epub 2007 May 22. Review.PMID: 17519300 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adjunctive therapy in community-acquired pneumonia.

    Wunderink RG.

    Semin Respir Crit Care Med. 2009 Apr;30(2):146-53. Epub 2009 Mar 18. Review.PMID: 19296414 [PubMed - indexed for MEDLINE]Related articles

    16.

    Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia.

    Chen CZ, Fan PS, Lin CC, Lee CH, Hsiue TR.

    J Formos Med Assoc. 2009 Mar;108(3):219-23.PMID: 19293037 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.

    Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group.

    Eur Respir J. 2008 Feb;31(2):349-55. Epub 2007 Oct 24.PMID: 17959641 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course.

    Coelho L, Póvoa P, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H.

    Crit Care. 2007;11(4):R92.PMID: 17723153 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

    Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettilä V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group.

    JAMA. 2003 Jul 9;290(2):238-47.PMID: 12851279 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Community-acquired pneumonia in the elderly: a practical guide to treatment.

    Lieberman D, Lieberman D.

    Drugs Aging. 2000 Aug;17(2):93-105. Review.PMID: 10984198 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity